yahoo_financeOriginal article
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
RegulatoryapprovedEsoGuard®Positive
AI Analysis
Summary
Lucid Diagnostics announced it has secured commercial coverage policies spanning multiple health plans for its EsoGuard® esophageal DNA test, expanding patient access to the diagnostic.
Outcome Details
Commercial coverage policy secured spanning multiple health plans
Importance:6/10
Sentiment:
0.70
coveragereimbursementdiagnosticsesophageal cancercommercial policy
Related Companies
Read the original article
Published by yahoo_finance on August 5, 2026 12:36 PM